Tarek Carlos Salman-Monte
Tarek Carlos Salman-Monte publishes mostly in Rheumatology, Pathology and Forensic Medicine and Immunology, on topics such as Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies and Systemic Sclerosis and Related Diseases.
- World rank
- #5,987,471 of 7,710,434 ranked researchers
- Rank in Spain
- #144,067 of 204,306
- Works
- 118
- Citations
- 757
- Citations per work
- 6.4
What does Tarek Carlos Salman-Monte research?
Tarek Carlos Salman-Monte's work is mostly in Medicine (64%), Immunology and Microbiology (7%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7664.1%
- Medicine7664.1%
- Everything else3429.2%
- Life Sciences86.7%
- 1Rheumatology38% of their works
- 2Pathology and Forensic Medicine14% of their works
- 3Immunology7% of their works
- 4Hematology4% of their works
- 5Pulmonary and Respiratory Medicine4% of their works
- 6Hepatology3% of their works
Research topics
- Systemic Lupus Erythematosus Research
- Rheumatoid Arthritis Research and Therapies
- Systemic Sclerosis and Related Diseases
- Spondyloarthritis Studies and Treatments
- Atherosclerosis and Cardiovascular Diseases
- Monoclonal and Polyclonal Antibodies Research
- Autoimmune and Inflammatory Disorders Research
- Liver Diseases and Immunity
Which keywords describe Tarek Carlos Salman-Monte's research?
The keywords of their largest research topics: Autoantibodies, Antiphospholipid Syndrome, Systemic Lupus Erythematosus, Cytokines, Inflammation, Immunosuppressive Therapy, Biological Therapy and Rheumatoid Arthritis.
- Primary Biliary Cirrhosis
- Hemophagocytic Lymphohistiocytosis
- Therapeutic Antibodies
- Fc Receptors
- Spondyloarthritis
- Systemic Sclerosis
- Rheumatoid Arthritis
- Immunosuppressive Therapy
- Cytokines
- Antiphospholipid Syndrome
- Autoantibodies
- Systemic Lupus Erythematosus
- Inflammation
- Biological Therapy
- Fibrosis
- Ankylosing Spondylitis
- Atherosclerosis
- Immune Response
- Autoimmune Hepatitis
- Juvenile Idiopathic Arthritis
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Autoantibodies1193 topics
- Antiphospholipid Syndrome711 topic
- Systemic Lupus Erythematosus711 topic
- Cytokines322 topics
- Inflammation322 topics
- Immunosuppressive Therapy292 topics
- Biological Therapy251 topic
- Rheumatoid Arthritis251 topic
- Fibrosis231 topic
- Systemic Sclerosis231 topic
- Ankylosing Spondylitis91 topic
- Spondyloarthritis91 topic
- Atherosclerosis71 topic
- Fc Receptors71 topic
- Immune Response71 topic
- Therapeutic Antibodies71 topic
- Autoimmune Hepatitis61 topic
- Hemophagocytic Lymphohistiocytosis61 topic
- Juvenile Idiopathic Arthritis61 topic
- Primary Biliary Cirrhosis61 topic
Where does Tarek Carlos Salman-Monte work?
Tarek Carlos Salman-Monte's main affiliation in the publication record is Parc de Salut, Spain.
How many publications and citations does Tarek Carlos Salman-Monte have?
OpenAlex counts 118 works and 757 citations for Tarek Carlos Salman-Monte, an h-index of 14, ranking #5,987,471 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Tarek Carlos Salman-Monte
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tarek Carlos Salman-Monte. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.